C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
530/13, 195/1.14
C12N 15/20 (2006.01) A61K 38/21 (2006.01) C07K 14/56 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1340184
The present invention provides new interferon polypeptides of Type 1 coded for by the cDNA inserts of plasmids P9A2 and E76E9 (deposited at the DSM within E.coli HB101 under the numbers DSM 3003 and 3004 respectively), further interferon polypeptides coded for by sequences which will hybridise with the sequences corresponding to the interferon-coding sequences of plasmids P9A2 and E76E9 or degenerate variations thereof under stringent hybridisation conditions suitable for detecting about 85% or higher homology, and N-glycosylated or other derivatives thereof with interferon activity. Such interferons have been designated omega interferons and are useful in treatments in which known interferons have been used, for example, herpes, rhinovirus and AIDS infections as well as certain cancers.
487921
Adolf Gunther
Hauel Norbert
Hauptmann Rudolf
Meindl Peter
Pieler Christian
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Cloning and characterizing omega-interferon and related genes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloning and characterizing omega-interferon and related genes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloning and characterizing omega-interferon and related genes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1224172